Paderi, A.; Fancelli, S.; Caliman, E.; Pillozzi, S.; Gambale, E.; Mela, M.M.; Doni, L.; Mazzoni, F.; Antonuzzo, L.
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study. Curr. Oncol. 2021, 28, 3259-3267.
https://doi.org/10.3390/curroncol28050283
AMA Style
Paderi A, Fancelli S, Caliman E, Pillozzi S, Gambale E, Mela MM, Doni L, Mazzoni F, Antonuzzo L.
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study. Current Oncology. 2021; 28(5):3259-3267.
https://doi.org/10.3390/curroncol28050283
Chicago/Turabian Style
Paderi, Agnese, Sara Fancelli, Enrico Caliman, Serena Pillozzi, Elisabetta Gambale, Marinella Micol Mela, Laura Doni, Francesca Mazzoni, and Lorenzo Antonuzzo.
2021. "Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study" Current Oncology 28, no. 5: 3259-3267.
https://doi.org/10.3390/curroncol28050283
APA Style
Paderi, A., Fancelli, S., Caliman, E., Pillozzi, S., Gambale, E., Mela, M. M., Doni, L., Mazzoni, F., & Antonuzzo, L.
(2021). Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study. Current Oncology, 28(5), 3259-3267.
https://doi.org/10.3390/curroncol28050283